Integrated models of care in managing inflammatory bowel disease: A discussion

被引：52

作者：

Mikocka-Walus, Antonina A. ^{[1
,2
]}

Andrews, Jane M. ^{[3
,4
]}

Bernstein, Charles N. ^{[5
,6
]}

Graff, Lesley A. ^{[5
,7
]}

Walker, John R. ^{[5
,7
]}

Spinelli, Antonino ^{[8
,9
]}

Danese, Silvio ^{[8
]}

van der Woude, C. Janneke ^{[10
]}

Goodhand, James ^{[11
]}

Rampton, David ^{[11
]}

Moser, Gabriele ^{[12
]}

机构：

[1] Univ S Australia, Sch Nursing & Midwifery, GPO Box 2471, Adelaide, SA 5001, Australia

[2] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia

[3] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, IBD Serv, Adelaide, SA 5000, Australia

[4] Univ Adelaide, Sch Med, Adelaide, SA, Australia

[5] Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada

[6] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada

[7] Univ Manitoba, Dept Clin Hlth Psychol, Winnipeg, MB, Canada

[8] Ist Clin Humanitas, Dept Surg, Milan, Italy

[9] Univ Milan, Fac Med, Dept Gen Surg 3, Milan, Italy

[10] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[11] Univ London, Barts & London Sch Med & Dent, Ctr Digest Dis, London, England

[12] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria

来源：

INFLAMMATORY BOWEL DISEASES | 2012年 / 18卷 / 08期

关键词：

biopsychosocial; inflammatory bowel disease; integrated model of care; psychotherapy; FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; IBD; MANAGEMENT; OUTCOMES; NEED; ANTIDEPRESSANTS; QUESTIONNAIRE; PERSPECTIVES; IMPACT;

D O I：

10.1002/ibd.22877

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The World Health Organization has recommended the integrated model of care as the current best practice of care, and, in recent years, it has been gaining popularity worldwide in various settings. However, there have been very few reports on applications of this model to the care of patients with gastrointestinal problems and no reports in the case of inflammatory bowel disease (IBD). However, several IBD centres worldwide have been using the model as part of their standard care. This discussion paper aims to bring together these units' shared experiences with a range of integrated models of care in order to identify common features and provide recommendations on aspirational care for IBD patients. (Inflamm Bowel Dis 2012)

引用

页码：1582 / 1587

页数：6

共 50 条

[21] Managing risks of neoplasia in inflammatory bowel disease
Velayos F.
Current Gastroenterology Reports, 2012, 14 (2) : 174 - 180
[22] Managing inflammatory bowel disease in adolescent patients
Bishop, J.
Lemberg, D. A.
Day, A. S.
ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2014, 5 : 1 - 13
[23] Inflammatory Bowel Disease: Managing Complex Patients
Miksa, Paula
Apperley, Shane Ryan
PHYSICIAN ASSISTANT CLINICS, 2021, 6 (04) : 655 - 665
[24] The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
Mathias, Holly
Rohatinsky, Noelle
Murthy, Sanjay K.
Novak, Kerri
Kuenzig, M. Ellen
Nguyen, Geoffrey C.
Fowler, Sharyle
Benchimol, Eric I.
Coward, Stephanie
Kaplan, Gilaad G.
Windsor, Joseph W.
Bernstein, Charles N.
Targownik, Laura E.
Pena-Sanchez, Juan-Nicolas
Lee, Kate
Ghandeharian, Sara
Jannati, Nazanin
Weinstein, Jake
Khan, Rabia
Im, James H. B.
Matthews, Priscilla
Davis, Tal
Goddard, Quinn
Gorospe, Julia
Latos, Kate
Louis, Michelle
Balche, Naji
Dobranowski, Peter
Patel, Ashley
Porter, Linda J.
Porter, Robert M.
Bitton, Alain
Jones, Jennifer L.
JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2023, 6 : S111 - S121
[25] The Birds, the Bees, and Inflammatory Bowel Disease: Preconception Care in Inflammatory Bowel Disease
McConnell, Ryan A.
Mahadevan, Uma
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (09) : 1293 - 1295
[26] Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy
Saibeni, Simone
Zanetti, Michela
Bezzio, Cristina
Pironi, Loris
Armuzzi, Alessandro
Riso, Sergio
Caprioli, Flavio
Lezo, Antonella
Macaluso, Fabio Salvatore
Pugliese, Daniela
Daperno, Marco
Giorgetti, Gian Marco
DIGESTIVE AND LIVER DISEASE, 2023, 55 (08) : 1028 - 1033
[27] Cytokines and inflammatory bowel disease - Final discussion
Jewell, DP
MacDonald, T
Sartor, RB
Cominelli, F
Mahida, YR
Ferguson, A
Tsang, MLS
Fiocchi, C
Elson, CO
Ottaway, CA
Brattsand, R
VanDeventer, SJH
Warren, BF
James, SP
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 113 - 117
[28] Osteoporosis as a risk in inflammatory bowel disease -: Discussion
Hanauer
Griffiths
Roca
Strober
Stockbrügger
Rolny
Rutgeerts
Steinhart
Gassull
Tremaine
Williams
DRUGS OF TODAY, 1999, 35 : 29 - 32
[29] Discussion on the biologic therapy of inflammatory bowel disease
Merger, M
Herfarth, H
Scholmerich, J
Andus, T
Färber, L
GASTROENTEROLOGY, 2003, 124 (07) : 2005 - 2006
[30] Epidemiology of inflammatory bowel disease in Spain -: Discussion
Gomollón
Ruiz-Ochoa
Saro
Bonilla
De Sola
Sierra
Pecasse
Ekbom
Colombel
Maté
DRUGS OF TODAY, 2001, 37 : 252 - 254

← 1 2 3 4 5 →